Kai Yoshiro, Hishida Yuichi
Department of Respiratory Medicine, Minami-Nara General Medical Center, Nara, Japan.
Department of Respiratory Medicine, Nara Medical University, Nara, Japan.
J Allergy Clin Immunol Glob. 2024 Dec 24;4(2):100398. doi: 10.1016/j.jacig.2024.100398. eCollection 2025 May.
Airway hyperresponsiveness, a key feature of asthma, is associated with exercise-induced asthma. Tezepelumab was reported to reduce airway hyperresponsiveness. Tezepelumab was confirmed through 3-dimensional bronchial tree visualization to be effective for exercise-induced asthma, reducing the need for a short-acting β2 agonist.
气道高反应性是哮喘的一个关键特征,与运动诱发性哮喘相关。据报道,tezepelumab可降低气道高反应性。通过三维支气管树可视化证实,tezepelumab对运动诱发性哮喘有效,减少了对短效β2激动剂的需求。